178
Capecchi M. R. 1989. Altering the genome by homologous recombination.
179
First N., Thomson J. 1998. From cows stem therapies?
180
Lyon J., Corner P. 1996.
181
Eto M., Watanabe K., Makino I. 1989. Increased frequencies of apolipoprotein
182
Lucotte G., Loirat F., Hazout S. 1997. Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe.
183
Kamboh M. I. 1995. Apolipoprotein E polymorphism and susceptibility to Alzheimer’s disease.
Flannery T. 1998.
184
Cook-Degan R. 1995.
185
Kamboh M. I. 1995. Apolipoprotein E polymorphism and susceptibility to Alzheimer’s disease.
Corder E. H. et al. 1994. Protective effect of apoipoprotein E type 2 allele for late onset Alzheimer disease.
186
Bickeboller H. et al. Apolipoprotein E and Alzheimer disease: genotypic-specific risks by age and sex.
Payami H. et al. 1996. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.
Tang M. X. et al. 1996. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.
187
Caldicott F. et al. 1998.
188
Maddox J. 1998.
189
Cookson C. 1998. Markers on the road to avoiding illness.
Schmidt K. 1998. Just for you.
190